APO Research
Talk to an analyst

APO RESEARCH · REPORT

Travelers Vaccines

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Selected research

Market Structure

Global Travelers Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025184 pages

Choose your research edition.

Industry ResearchTravelers Vaccines Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Travelers Vaccines Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Travelers Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Travelers Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Travelers Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Read the full market overview

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

This report provides an overview of the global Travelers Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Travelers Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Travelers Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Travelers Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Travelers Vaccines Segment by Company

GlaxoSmithKline

Sanofi Pasteur

Merck

Pfizer

CNBG

Sanofi Pasteur MSD

Serum Institute of India

Biokangtai

Travelers Vaccines Segment by Type

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Yellow Fever Vaccine

Hepatitis Vaccine

Cholera Vaccine

Other

Travelers Vaccines Segment by End Users

Tourists

Students

Workers

Others

Travelers Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Travelers Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Travelers Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Travelers Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Travelers Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Travelers Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Travelers Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Travelers Vaccines Industry Trends Table 2. Travelers Vaccines Industry Drivers Table 3. Travelers Vaccines Industry Opportunities and Challenges Table 4. Travelers Vaccines Industry Restraints Table 5. Global Travelers Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Travelers Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Travelers Vaccines Sales by Manufacturers (k doses) & (2021-2026) Table 8. Global Travelers Vaccines Sales Market Share by Manufacturers Table 9. Global Travelers Vaccines Average Sales Price (USD/dose) of Manufacturers (2021-2026) Table 10. Global Travelers Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Travelers Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Travelers Vaccines Manufacturers, Product Type & Application Table 13. Global Travelers Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Travelers Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Meningococcal Vaccine Table 17. Major Manufacturers of Japanese Encephalitis Vaccine Table 18. Major Manufacturers of Yellow Fever Vaccine Table 19. Major Manufacturers of Hepatitis Vaccine Table 20. Major Manufacturers of Cholera Vaccine Table 21. Major Manufacturers of Other Table 22. Global Travelers Vaccines Sales by Type 2021 VS 2025 VS 2032 (k doses) Table 23. Global Travelers Vaccines Sales by Type (2021-2026) & (k doses) Table 24. Global Travelers Vaccines Sales by Type (2027-2032) & (k doses) Table 25. Global Travelers Vaccines Sales Market Share by Type (2021-2026) Table 26. Global Travelers Vaccines Sales Market Share by Type (2027-2032) Table 27. Global Travelers Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k doses) Table 28. Global Travelers Vaccines Revenue by Type (2021-2026) & (k doses) Table 29. Global Travelers Vaccines Revenue by Type (2027-2032) & (k doses) Table 30. Global Travelers Vaccines Revenue Market Share by Type (2021-2026) Table 31. Global Travelers Vaccines Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Tourists Table 33. Major Manufacturers of Students Table 34. Major Manufacturers of Workers Table 35. Major Manufacturers of Others Table 36. Global Travelers Vaccines Sales by Application 2021 VS 2025 VS 2032 (k doses) Table 37. Global Travelers Vaccines Sales by Application (2021-2026) & (k doses) Table 38. Global Travelers Vaccines Sales by Application (2027-2032) & (k doses) Table 39. Global Travelers Vaccines Sales Market Share by Application (2021-2026) Table 40. Global Travelers Vaccines Sales Market Share by Application (2027-2032) Table 41. Global Travelers Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k doses) Table 42. Global Travelers Vaccines Revenue by Application (2021-2026) & (k doses) Table 43. Global Travelers Vaccines Revenue by Application (2027-2032) & (k doses) Table 44. Global Travelers Vaccines Revenue Market Share by Application (2021-2026) Table 45. Global Travelers Vaccines Revenue Market Share by Application (2027-2032) Table 46. Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k doses) Table 47. Global Travelers Vaccines Sales by Region (2021-2026) & (k doses) Table 48. Global Travelers Vaccines Sales Market Share by Region (2021-2026) Table 49. Global Travelers Vaccines Sales Forecasted by Region (2027-2032) & (k doses) Table 50. Global Travelers Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 52. North America Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 53. North America Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 54. Europe Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 55. Europe Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 56. Europe Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 57. Asia Pacific Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 58. Asia Pacific Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 59. Asia Pacific Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 60. South America, Middle East and Africa Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k doses) Table 61. South America, Middle East and Africa Travelers Vaccines Sales by Country (2021-2026) & (k doses) Table 62. South America, Middle East and Africa Travelers Vaccines Sales by Country (2027-2032) & (k doses) Table 63. Global Travelers Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Travelers Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Travelers Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Travelers Vaccines Revenue Market Share by Region (2021-2026) Table 67. Global Travelers Vaccines Revenue Market Share by Region (2027-2032) Table 68. GlaxoSmithKline Company Information Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Travelers Vaccines Product Portfolio Table 72. GlaxoSmithKline Recent Development Table 73. Sanofi Pasteur Company Information Table 74. Sanofi Pasteur Business Overview Table 75. Sanofi Pasteur Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Pasteur Travelers Vaccines Product Portfolio Table 77. Sanofi Pasteur Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck Travelers Vaccines Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Travelers Vaccines Product Portfolio Table 87. Pfizer Recent Development Table 88. CNBG Company Information Table 89. CNBG Business Overview Table 90. CNBG Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. CNBG Travelers Vaccines Product Portfolio Table 92. CNBG Recent Development Table 93. Sanofi Pasteur MSD Company Information Table 94. Sanofi Pasteur MSD Business Overview Table 95. Sanofi Pasteur MSD Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanofi Pasteur MSD Travelers Vaccines Product Portfolio Table 97. Sanofi Pasteur MSD Recent Development Table 98. Serum Institute of India Company Information Table 99. Serum Institute of India Business Overview Table 100. Serum Institute of India Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Serum Institute of India Travelers Vaccines Product Portfolio Table 102. Serum Institute of India Recent Development Table 103. Biokangtai Company Information Table 104. Biokangtai Business Overview Table 105. Biokangtai Travelers Vaccines Sales (k doses), Price (USD/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Biokangtai Travelers Vaccines Product Portfolio Table 107. Biokangtai Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Travelers Vaccines Distributors List Table 111. Travelers Vaccines Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Travelers Vaccines Product Image Figure 2. Global Travelers Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Travelers Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Travelers Vaccines Sales (2021-2032) & (k doses) Figure 5. Global Travelers Vaccines Average Price (USD/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Travelers Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Meningococcal Vaccine Image Figure 9. Japanese Encephalitis Vaccine Image Figure 10. Yellow Fever Vaccine Image Figure 11. Hepatitis Vaccine Image Figure 12. Cholera Vaccine Image Figure 13. Other Image Figure 14. Global Travelers Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k doses) Figure 15. Global Travelers Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Travelers Vaccines Sales Market Share by Type (2021-2032) Figure 17. Global Travelers Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k doses) Figure 18. Global Travelers Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Travelers Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Tourists Image Figure 21. Students Image Figure 22. Workers Image Figure 23. Others Image Figure 24. Global Travelers Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k doses) Figure 25. Global Travelers Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Travelers Vaccines Sales Market Share by Application (2021-2032) Figure 27. Global Travelers Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k doses) Figure 28. Global Travelers Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Travelers Vaccines Revenue Market Share by Application (2021-2032) Figure 30. North America Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 31. North America Travelers Vaccines Sales Market Share by Country (2021-2032) Figure 32. U.S. Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 33. Canada Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 34. Mexico Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 35. Europe Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 36. Europe Travelers Vaccines Sales Market Share by Country (2021-2032) Figure 37. Germany Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 38. France Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 39. U.K. Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 40. Italy Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 41. Netherlands Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 42. Asia Pacific Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 43. Asia Pacific Travelers Vaccines Sales Market Share by Country (2021-2032) Figure 44. China Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 45. Japan Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 46. South Korea Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 47. Southeast Asia Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 48. India Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 49. Australia Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 50. South America, Middle East and Africa Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 51. South America, Middle East and Africa Travelers Vaccines Sales Market Share by Country (2021-2032) Figure 52. Brazil Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 53. South Africa Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 54. Saudi Arabia Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 55. Turkey Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 56. Argentina Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 57. UAE Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 58. Egypt Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 59. Chile Travelers Vaccines Sales and Growth Rate (2021-2032) & (k doses) Figure 60. Global Travelers Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Travelers Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Travelers Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. North America Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Travelers Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. Europe Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Travelers Vaccines Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Travelers Vaccines Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Travelers Vaccines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Travelers Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Yellow Fever Vaccine
  • Hepatitis Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Tourists
  • Students
  • Workers
  • Others
Companies covered
  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Pfizer
  • CNBG
  • Sanofi Pasteur MSD
  • Serum Institute of India
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Travelers Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Travelers Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Travelers Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Travelers Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Travelers Vaccines Market Dynamics
  1. 2.1 Travelers Vaccines Industry Trends
  2. 2.2 Travelers Vaccines Industry Drivers
  3. 2.3 Travelers Vaccines Industry Opportunities and Challenges
  4. 2.4 Travelers Vaccines Industry Restraints
3 Travelers Vaccines Market by Manufacturers
  1. 3.1 Global Travelers Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Travelers Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Travelers Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Travelers Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Travelers Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Travelers Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Travelers Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Travelers Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Travelers Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Travelers Vaccines Tier 1, Tier 2, and Tier 3
4 Travelers Vaccines Market by Type
  1. 4.1 Travelers Vaccines Type Introduction
  2. 4.1.1 Meningococcal Vaccine
  3. 4.1.2 Japanese Encephalitis Vaccine
  4. 4.1.3 Yellow Fever Vaccine
  5. 4.1.4 Hepatitis Vaccine
  6. 4.1.5 Cholera Vaccine
  7. 4.1.6 Other
  8. 4.2 Global Travelers Vaccines Sales by Type
  9. 4.2.1 Global Travelers Vaccines Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Travelers Vaccines Sales by Type (2021-2032)
  11. 4.2.3 Global Travelers Vaccines Sales Market Share by Type (2021-2032)
  12. 4.3 Global Travelers Vaccines Revenue by Type
  13. 4.3.1 Global Travelers Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Travelers Vaccines Revenue by Type (2021-2032)
  15. 4.3.3 Global Travelers Vaccines Revenue Market Share by Type (2021-2032)
5 Travelers Vaccines Market by Application
  1. 5.1 Travelers Vaccines Application Introduction
  2. 5.1.1 Tourists
  3. 5.1.2 Students
  4. 5.1.3 Workers
  5. 5.1.4 Others
  6. 5.2 Global Travelers Vaccines Sales by Application
  7. 5.2.1 Global Travelers Vaccines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Travelers Vaccines Sales by Application (2021-2032)
  9. 5.2.3 Global Travelers Vaccines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Travelers Vaccines Revenue by Application
  11. 5.3.1 Global Travelers Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Travelers Vaccines Revenue by Application (2021-2032)
  13. 5.3.3 Global Travelers Vaccines Revenue Market Share by Application (2021-2032)
6 Global Travelers Vaccines Sales by Region
  1. 6.1 Global Travelers Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Travelers Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Travelers Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Travelers Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Travelers Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Travelers Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Travelers Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Travelers Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Travelers Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Travelers Vaccines Revenue by Region
  1. 7.1 Global Travelers Vaccines Revenue by Region
  2. 7.1.1 Global Travelers Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Travelers Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Travelers Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Travelers Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Travelers Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Travelers Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Travelers Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Travelers Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Travelers Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline
  2. 8.1.1 GlaxoSmithKline Company Information
  3. 8.1.2 GlaxoSmithKline Business Overview
  4. 8.1.3 GlaxoSmithKline Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Travelers Vaccines Product Portfolio
  6. 8.1.5 GlaxoSmithKline Recent Developments
  7. 8.2 Sanofi Pasteur
  8. 8.2.1 Sanofi Pasteur Company Information
  9. 8.2.2 Sanofi Pasteur Business Overview
  10. 8.2.3 Sanofi Pasteur Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Pasteur Travelers Vaccines Product Portfolio
  12. 8.2.5 Sanofi Pasteur Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Travelers Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Travelers Vaccines Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 CNBG
  26. 8.5.1 CNBG Company Information
  27. 8.5.2 CNBG Business Overview
  28. 8.5.3 CNBG Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CNBG Travelers Vaccines Product Portfolio
  30. 8.5.5 CNBG Recent Developments
  31. 8.6 Sanofi Pasteur MSD
  32. 8.6.1 Sanofi Pasteur MSD Company Information
  33. 8.6.2 Sanofi Pasteur MSD Business Overview
  34. 8.6.3 Sanofi Pasteur MSD Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur MSD Travelers Vaccines Product Portfolio
  36. 8.6.5 Sanofi Pasteur MSD Recent Developments
  37. 8.7 Serum Institute of India
  38. 8.7.1 Serum Institute of India Company Information
  39. 8.7.2 Serum Institute of India Business Overview
  40. 8.7.3 Serum Institute of India Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Serum Institute of India Travelers Vaccines Product Portfolio
  42. 8.7.5 Serum Institute of India Recent Developments
  43. 8.8 Biokangtai
  44. 8.8.1 Biokangtai Company Information
  45. 8.8.2 Biokangtai Business Overview
  46. 8.8.3 Biokangtai Travelers Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biokangtai Travelers Vaccines Product Portfolio
  48. 8.8.5 Biokangtai Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Travelers Vaccines Value Chain Analysis
  2. 9.1.1 Travelers Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Travelers Vaccines Production Mode & Process
  6. 9.2 Travelers Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Travelers Vaccines Distributors
  9. 9.2.3 Travelers Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst